Estradiol release kinetics determine tissue response in ovariectomized rats

Endocrinology

Volumn 153, Issue 4, 2012, Pages 1725-1733

  Otto, Christiane ^a   Kantner, Ingrid ^b   Nubbemeyer, Reinhard ^a   Schkoldow, Jenny ^a   Fuchs, Iris ^a   Krahl, Elisabeth ^a   Vonk, Richardus ^a   Schüler, Christiane ^b   Fritzemeier, Karl Heinrich ^a   Erben, Reinhold G ^b  

^a BAYER PHARMA AG   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BENZYL BENZOATE; CASTOR OIL; ESTRADIOL; ESTROGEN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BREAST EPITHELIUM; BREAST HYPERPLASIA; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG RELEASE; ENDOMETRIUM; ESTROGEN THERAPY; FEMALE; GENE INDUCTION; HOT FLUSH; LIVER; MENOPAUSAL SYNDROME; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; UTERUS WEIGHT; VAGINA ATROPHY; VAGINAL DRYNESS;

ANIMALS; ATROPHY; BONE AND BONES; BONE DENSITY; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HYPERPLASIA; INJECTIONS; LIVER; MAMMARY GLANDS, ANIMAL; MODELS, ANIMAL; OVARIECTOMY; RATS; RATS, WISTAR; TIME FACTORS; UTERUS; VAGINA;

EID: 84859418008     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1801     Document Type: Article

References (20)

1. Hulka BS, Chambless LE, Kaufman DG, Fowler Jr WC, Greenberg BG 1982 Protection against endometrial carcinoma by combination- product oral contraceptives. JAMA 247:475-477 (Pubitemid 12203031)
2. Hofseth LJ, Raafat AM, Osuch JR, Pathak DR, Slomski CA, Haslam SZ 1999 Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J Clin Endocrinol Metab 84:4559-4565
3. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288: 321-333
4. von Schoultz B, Carlström K, Collste L, Eriksson A, Henrikkson P, Pousette A, Stege R 1989 Estrogen therapy and liver function-metabolic effects of oral and parenteral administration. Prostate 14:389-395 (Pubitemid 19208212)
5. Enmark E, Gustafsson JA 1999 Oestrogen receptors-an overview. J Intern Med 246:133-138
6. Acconcia F, Kumar R 2006 Signaling regulation of genomic and nongenomic functions of estrogen receptors. Cancer Lett 238:1-14 (Pubitemid 43851144)
7. Smith CL, O'Malley BW 2004 Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 25:45-71 (Pubitemid 38292038)
8. Hillisch A, Peters O, Kosemund D, Müller G, Walter A, Schneider B, Reddersen G, Elger W, Fritzemeier KH 2004 Dissecting physiological roles of estrogen receptor α and β with potent selective ligands from structure-based design. Mol Endocrinol 18:1599-1609 (Pubitemid 38859569)
9. Otto C, Fuchs I, Altmann H, Klewer M, Schwarz G, Bohlmann R, Nguyen D, Zorn L, Vonk R, Prelle K, Osterman T, Malmström C, Fritzemeier KH 2008 In vivo characterization of estrogen receptor modulators with reduced genomic versus nongenomic activity in vitro. J Steroid Biochem Mol Biol 111:95-100
10. Devissaguet JP, Brion N, Lhote O, Deloffre P 1999 Pulsed estrogen therapy: pharmacokinetics of intranasal 17-β-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulations. Eur J Drug Metab Pharmacokinet 24:265-271 (Pubitemid 30077016)
11. Cavaillès V, Gompel A, Portois MC, Thénot S, Mabon N, Vignon F 2002 Comparative activity of pulsed or continuous estradiol exposure on gene expression and proliferation of normal and tumoral human breast cells. J Mol Endocrinol 28:165-175 (Pubitemid 34662221)
12. Simoncini T, Fornari L, Mannella P, Varone G, Caruso A, Garibaldi S, Genazzani AR 2005 Differential estrogen signalling in endothelial cells upon pulsed or continuous administration. Maturitas 50:247-258 (Pubitemid 40365027)
13. Diel P, Laudenbach-Leschowsky U, Friedel A, Voss A, Roussel J 2005 Pulsed estradiol exposure has a limited ability to induce uterine proliferation in ovariectomized female Wistar rats. Mol Cell Endocrinol 230:7-15 (Pubitemid 40138965)
14. Dören M, Al Azzawi F, Donnez J, Van der Mooren MJ, Villero J, Gompel A 2001 Therapeutic value and long-term safety of pulsed estrogen therapy. Maturitas 38(Suppl 1):S23-S30 (Pubitemid 33713158)
15. Rozenberg S, Pornel B, Koninckx PR, Palacios S, Christiansen C 2009 Endometrium protection and acceptability of nasally administered continuously combined hormone therapy: a multicentre, multinational, double-blind trial in post-menopausal women evaluating three regimens of 17β-estradiol and norethisterone when compared with an orally administered 17β-estradiol norethisterone regimen. Hum Reprod 24:1739-1747
16. Sahlin L, Elger W, Akerberg S, Masironi B, Reddersen G, Schneider B, Schwarz S, Freyschuss B, Eriksson H 2000 Effects of estradiol and estradiol sulfamate on the uterus of ovariectomized or ovariectomized and hypophysectomised rats. J Steroid Biochem Mol Biol 74:99-107
17. Kronenberg MS, Clark JH 1985 Changes in keratin expression during the estrogen-mediated differentiation of rat vaginal epithelium. Endocrinology 117:1480-1489 (Pubitemid 15238128)
18. Otto C, Fuchs I, Altmann H, Klewer M, Walter A, Prelle K, Vonk R, Fritzemeier KH 2008 Comparative analysis of the uterine and mammary gland effects of drospirenone and medroxyprogesterone acetate. Endocrinology 149:3952-3959
19. Simoncini T, Fornari L, Mannella P, Varone G, Caruso A, Liao JK, Genazzani AR 2002 Novel non-transcriptional mechanisms for estrogen receptor signalling in the cardiovascular system. Interaction of estrogen receptor α with phosphatidylinositol 3-OH kinase. Steroids 67:935-939
20. Ahlbory-Dieker DL, Stride BD, Leder G, Schkoldow J, Trölenberg S, Seidel H, Otto C, Sommer A, Parker MG, Schütz G, Wintermantel TM 2009 DNA binding by estrogen receptor-α is essential for the transcriptional response to estrogen in the liver and the uterus. Mol Endocrinol 23:1544-1555